12-56453715-T-G
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_012064.4(MIP):c.401A>C(p.Glu134Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E134G) has been classified as Pathogenic.
Frequency
Consequence
NM_012064.4 missense
Scores
Clinical Significance
Conservation
Publications
- cataract 15 multiple typesInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- cerulean cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset lamellar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset nuclear cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset posterior polar cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset sutural cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- total early-onset cataractInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_012064.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MIP | NM_012064.4 | MANE Select | c.401A>C | p.Glu134Ala | missense | Exon 2 of 4 | NP_036196.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MIP | ENST00000652304.1 | MANE Select | c.401A>C | p.Glu134Ala | missense | Exon 2 of 4 | ENSP00000498622.1 | ||
| MIP | ENST00000555551.1 | TSL:1 | n.357A>C | non_coding_transcript_exon | Exon 2 of 3 | ||||
| ENSG00000285528 | ENST00000648304.1 | n.*25A>C | non_coding_transcript_exon | Exon 2 of 4 | ENSP00000497190.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
The E134A variant in the MIP gene has not been reported previously as a pathogenic variant, nor as abenign variant, to our knowledge. However, a missense variant at this same codon (E134G) has beenreported in a large family with autosomal dominant congenital cataracts (Berry et al., 2000). TheE134A variant was not observed in approximately 6500 individuals of European and AfricanAmerican ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benignvariant in these populations. The E134A variant is a non-conservative amino acid substitution, whichis likely to impact secondary protein structure as these residues differ in polarity, charge, size and/orother properties. In addition, this substitution occurs at a position that is conserved across species, andin silico analysis predicts this variant is probably damaging to the protein structure/function. TheE134A variant is a strong candidate for a pathogenic variant, however the possibility it may be a rarebenign variant cannot be excluded.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at